GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO, S.L.;MONASH UNIVERSITY;UNIVERSITY OF WASHINGTON;BOARD OF REGENTS;MEDICINES FOR MALARIA VENTURE;BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM; THE UNIVERSITY OF TEXAS SYSTEM
Inhibitors of parasitic dihydroorotate dehydrogenase enzyme (DHOD) are candidate therapeutics for treating malaria. Illustrative of such therapeutic agents include the compound: and a triazolopyrimidine class of compounds that conform to Formula IX: and their solvates, stereoisomers, tautomers and pharmaceutically acceptable salts.